The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benef ....Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benefit to the Australian economy improving the quality of life enabling people to work longer and reducing the need for further surgical intervention. This proposal will also have benefits to Australia through training future researchers in this field which will in turn provide economic growth through the development of Australian industries.Read moreRead less
Switching the light on cartilage repair. Osteoarthritis is a leading cause of pain and disability in adults and affects 15 per cent of the Australian population. This project will develop a revolutionary new approach to treat joint disorders using smart materials and stem cells. The novel materials and techniques developed will help Australia maintain its leading edge in biotechnology.
Industrial Transformation Training Centres - Grant ID: IC170100022
Funder
Australian Research Council
Funding Amount
$4,420,408.00
Summary
ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess a ....ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess and optimise the healing process. In addition, the Centre will produce data for use in deriving the next-generation of implants, giving rise to improved health outcomes, economic benefits, and a skilled workforce able to advance and perpetuate this important field.Read moreRead less
Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is e ....Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is expected to increase with the ageing population. This work leads to the development of a novel cartilage engineering technology platform that addresses Frontier Technologies and will thus provide the foundation for translation of this technology to the international marketplace. Read moreRead less
Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor ....Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor scarcity in meniscal repair. Success in this project will lead directly to large-animal studies and clinical trials. The training of four early careeer researchers involved in this project will also be of significant benefit to the Australian Tissue Engineering and Biomaterials community.Read moreRead less
The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the heal ....The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the health and well-being of Australians. The research falls within the Designated National Research Priority of Frontier Technologies for Building and Transforming Australian Industries.Read moreRead less
Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasm ....Modulation of protein folding pathways: a new platform technology for molecular medicine. Misfolding of proteins is becoming recognised as a major cause of inherited disease. We propose to develop a chemical agent that will optimise the folding of alpha1-antitrypsin (AAT), misfolding of which gives rise to inheritable liver and lung disease. This agent will have potential application as a therapy for sufferers of AAT-misfolding disease and for improving the yield of AAT purified from human plasma, which is the current agent used to treat patients with AAT-misfolding disease.Read moreRead less
Patient-specific biomechanical modelling for improved treatment of spinal deformity. Spinal deformities negatively affect social acceptance, physical and mental wellbeing in children and adolescents. The direct costs of spinal deformity surgery are approximately $30 million per year in Australia, yet poor treatment outcomes due to post-operative complications incur a much higher cost as patients with persistent pain and disability face a lifetime of dependency and reduced ability to work. The pa ....Patient-specific biomechanical modelling for improved treatment of spinal deformity. Spinal deformities negatively affect social acceptance, physical and mental wellbeing in children and adolescents. The direct costs of spinal deformity surgery are approximately $30 million per year in Australia, yet poor treatment outcomes due to post-operative complications incur a much higher cost as patients with persistent pain and disability face a lifetime of dependency and reduced ability to work. The patient-specific biomechanical modelling techniques developed in this project will reduce complications and improve correction for Australian children who undergo spinal deformity surgery. Better treatment outcomes will ensure quality of life, health and productivity for spinal deformity patients throughout their entire lives.Read moreRead less
The virtual human knee. This project aims to investigate the Virtual Human Knee (VHK) which provides a baseline knowledge about knee mechanics in healthy individuals and a tool for studying knee mechanics in silico. The new knowledge can be used for identifying individuals most at risk for injury, developing solutions for preventing injury and for assessing knee reconstruction and implantation methods. As such, VHK will mitigate the burden of knee injury to Australia and worldwide by progressing ....The virtual human knee. This project aims to investigate the Virtual Human Knee (VHK) which provides a baseline knowledge about knee mechanics in healthy individuals and a tool for studying knee mechanics in silico. The new knowledge can be used for identifying individuals most at risk for injury, developing solutions for preventing injury and for assessing knee reconstruction and implantation methods. As such, VHK will mitigate the burden of knee injury to Australia and worldwide by progressing disciplines including anatomy, bio-mechanics, sport science, rehabilitation, surgery and medical devices.Read moreRead less
Formation of bone-like materials for bone repair and regeneration. A successful outcome for this project would lead to the production and application of new bone-like calcium phosphate materials. Enhanced bioactivity of this material would lead to higher but controlled rates of calcium phosphate release. An understanding of the formation process of these materials and the controlled release of calcium phosphates has the potential to slow the development of metabolic diseases such as osteoporosis ....Formation of bone-like materials for bone repair and regeneration. A successful outcome for this project would lead to the production and application of new bone-like calcium phosphate materials. Enhanced bioactivity of this material would lead to higher but controlled rates of calcium phosphate release. An understanding of the formation process of these materials and the controlled release of calcium phosphates has the potential to slow the development of metabolic diseases such as osteoporosis. The WHO reports that osteoporosis is the second largest health care problem world-wide. In 2002, 44 million people in the USA were estimated to be at risk. This and similar figures in Australia and around the world emphasize the urgency of understanding and appropriately combating weak bone degenerative diseases.Read moreRead less